Union européenne - tchèque - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanom - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.

Union européenne - tchèque - EMA (European Medicines Agency)

accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastická činidla - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.

Union européenne - tchèque - EMA (European Medicines Agency)

yes pharmaceutical development services gmbh - hydrochlorid doxorubicinu - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastická činidla - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).

Union européenne - tchèque - EMA (European Medicines Agency)

astrazeneca ab - tremelimumab - carcinoma, hepatocellular - antineoplastická činidla - imjudo in combination with durvalumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc). imjudo in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (nsclc) with no sensitising egfr mutations or alk positive mutations.

Union européenne - tchèque - EMA (European Medicines Agency)

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastická činidla - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.

République tchèque - tchèque - SUKL (Státní ústav pro kontrolu léčiv)

ardez pharma, spol. s r.o., kosoř array - 1456 kyselina thioktovÁ - potahovaná tableta - 600mg - kyselina thioktovÁ

République tchèque - tchèque - SUKL (Státní ústav pro kontrolu léčiv)

viatris healthcare limited, dublin array - 14912 trometamol-tioktÁt - injekční roztok - 600mg - kyselina thioktovÁ

République tchèque - tchèque - SUKL (Státní ústav pro kontrolu léčiv)

viatris healthcare limited, dublin array - 1456 kyselina thioktovÁ - potahovaná tableta - 600mg - kyselina thioktovÁ

République tchèque - tchèque - SUKL (Státní ústav pro kontrolu léčiv)

zentiva, k.s., praha array - 1456 kyselina thioktovÁ - potahovaná tableta - 600mg - kyselina thioktovÁ

République tchèque - tchèque - SUKL (Státní ústav pro kontrolu léčiv)

wörwag pharma gmbh & co. kg, böblingen array - 1456 kyselina thioktovÁ - potahovaná tableta - 600mg - kyselina thioktovÁ